Rashmita Sahoo
Research Subjects
Rashmita Sahoo has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Arindam Banerjee
2 shared publicationsShivangi Wani
2 shared publicationsAruna Korlimarla
Triesta Sciences (I) Private Limited, Sampangiram Nagar, Bangalore - India
1 shared publication- Aruna Korlimarla
Affiliation: Division of Molecular Medicine, St. John’s Research Institute, Bangalore, India
1 shared publication Ashwini Nargund
1 shared publicationB.S. Ajai Kumar
1 shared publication
Latest Publications
- 1 September 2011
- Published by Elsevier in Lung Cancer
- Vol. 73 (3) , 316-319
Screening for EGFR mutations in lung cancer, a report from India
- 1 September 2011
- Published by Elsevier in Lung Cancer
- Vol. 73 (3) , 316-319
Screening for EGFR mutations in lung cancer, a report from India
- 26 March 2009
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 24 (1) , 57-62
Gene-specific methylation: potential markers for colorectal cancer
- 26 March 2009
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 24 (1) , 57-62
Gene-specific methylation: potential markers for colorectal cancer
- 15 January 2009
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 24 (1) , 57-62
Gene-Specific Methylation: Potential Markers for Colorectal Cancer
Aberrant methylation of the promoter region is associated with silencing of many genes in neoplasia. CpG island methylation is an epigenetic mechanism for transcriptional silencing that occurs at various stages of colon tumorigenesis. In this study, we tested the promoter methylation and expression of seven genes from various pathways of DNA repair, apoptosis and inflammation, i.e., sFRP1, MLH1, RASSF1A, CDA, v-fgr, LYN-B, and TNFR10d. The genes were analyzed by quantitative polymerase chain reaction for the level of gene expression. The promoter methylation status of the genes was studied by methylation-specific polymerase chain reaction. The correlation of promoter methylation status with suppressed gene expression patterns suggested a potential role for the silencing these genes in colon cancer progression. Promoter methylations of the studied genes could be explored as promising biomarkers for new diagnostic, prognostic and therapeutic targets of colorectal cancer.
- 15 January 2009
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 24 (1) , 57-62
Gene-Specific Methylation: Potential Markers for Colorectal Cancer
Aberrant methylation of the promoter region is associated with silencing of many genes in neoplasia. CpG island methylation is an epigenetic mechanism for transcriptional silencing that occurs at various stages of colon tumorigenesis. In this study, we tested the promoter methylation and expression of seven genes from various pathways of DNA repair, apoptosis and inflammation, i.e., sFRP1, MLH1, RASSF1A, CDA, v-fgr, LYN-B, and TNFR10d. The genes were analyzed by quantitative polymerase chain reaction for the level of gene expression. The promoter methylation status of the genes was studied by methylation-specific polymerase chain reaction. The correlation of promoter methylation status with suppressed gene expression patterns suggested a potential role for the silencing these genes in colon cancer progression. Promoter methylations of the studied genes could be explored as promising biomarkers for new diagnostic, prognostic and therapeutic targets of colorectal cancer.